<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(18)</volume><submitter>Yamada N</submitter><pubmed_abstract>We investigated the effects of &lt;i>Lactobacillus paragasseri&lt;/i> OLL2716 on gastrointestinal symptoms in healthy adults with gastric complaints. In this randomized, double-blind, placebo-controlled trial, 174 healthy Japanese adults were randomly assigned to an OLL2716 or placebo group, and each group consumed 85 g of yogurt containing &lt;i>L. paragasseri&lt;/i> OLL2716 or placebo yogurt daily for 12 weeks. The primary endpoint was the change in gastric symptoms from baseline as per the participants' questionnaires at 6 and 12 weeks. The secondary endpoints were changes from baseline in the short-form Nepean Dyspepsia Index (SF-NDI), the Gastrointestinal Symptom Rating Scale (GSRS), and the Council on Nutrition Appetite Questionnaire-Japanese (CNAQ-J) scores at 6 and 12 weeks. The primary endpoi</pubmed_abstract><journal>Nutrients</journal><pagination>3188</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11434869</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Beneficial Effects of Regular Intake of &amp;lt;i&amp;gt;Lactobacillus paragasseri&amp;lt;/i&amp;gt; OLL2716 on Gastric Discomfort in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study.</pubmed_title><pmcid>PMC11434869</pmcid><pubmed_authors>Toshimitsu T</pubmed_authors><pubmed_authors>Sato A</pubmed_authors><pubmed_authors>Kano H</pubmed_authors><pubmed_authors>Yamada N</pubmed_authors><pubmed_authors>Nagira A</pubmed_authors><pubmed_authors>Hojo K</pubmed_authors><pubmed_authors>Kobayashi K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Beneficial Effects of Regular Intake of &amp;lt;i&amp;gt;Lactobacillus paragasseri&amp;lt;/i&amp;gt; OLL2716 on Gastric Discomfort in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study.</name><description>We investigated the effects of &lt;i>Lactobacillus paragasseri&lt;/i> OLL2716 on gastrointestinal symptoms in healthy adults with gastric complaints. In this randomized, double-blind, placebo-controlled trial, 174 healthy Japanese adults were randomly assigned to an OLL2716 or placebo group, and each group consumed 85 g of yogurt containing &lt;i>L. paragasseri&lt;/i> OLL2716 or placebo yogurt daily for 12 weeks. The primary endpoint was the change in gastric symptoms from baseline as per the participants' questionnaires at 6 and 12 weeks. The secondary endpoints were changes from baseline in the short-form Nepean Dyspepsia Index (SF-NDI), the Gastrointestinal Symptom Rating Scale (GSRS), and the Council on Nutrition Appetite Questionnaire-Japanese (CNAQ-J) scores at 6 and 12 weeks. The primary endpoi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-18T19:44:50.748Z</modification><creation>2025-04-07T07:32:04.367Z</creation></dates><accession>S-EPMC11434869</accession><cross_references><pubmed>39339788</pubmed><doi>10.3390/nu16183188</doi></cross_references></HashMap>